FT Global Pharmaceutical & Biotechnology Conference
Services
-
ConvergeHEALTH Connect for Crisis Response
In response to the spread of coronavirus around the world, Deloitte has developed an accelerator designed to enable health care organisations to digitally triage, monitor and remotely manage treatment of coronavirus patients and quarantined persons.
-
Biotech-in-a-box™️
Biotech-in-a-box™️ aims to provide a ‘one-stop shop’ for small-to-medium size life sciences companies to de-risk the scaling up of their business by leveraging Deloitte’s portfolio of capabilities.
-
The Future of Manufacturing Operations
The Future of Manufacturing Operations is Deloitte’s unique approach to help you reshape your business through digital transformation.
-
Pharmaceuticals
Deloitte has extensive relationships with pharmaceutical companies across the whole spectrum of size and geography.
-
Biotechnology
Switzerland is one of the top biotechnology locations in Europe. Biotechnology remains a firm agenda item in the approach to drug development and Switzerland is leading the way.
-
Medical devices
Switzerland is one of the leading Medtech locations globally. In relation to per capita Switzerland is the 2nd most important Medtech region worldwide.
-
Integration Advisory
Integrations involve multiple challenges, requiring your teams to master both the unknown and business as usual. We help you deliver target and transition state planning, successful integrations and long term value.
-
Regulatory Compliance Controls
The introduction of enhanced regulation coupled with the increased enforcement of legislation such as Anti-Trust & Competition law and the Data Protection Act has resulted in high profile breaches and significant penalties for across sectors.
